scholarly journals The clinically available NMDA receptor antagonist, memantine, exhibits relative safety in the developing rat brain

2011 ◽  
Vol 29 (7) ◽  
pp. 767-773 ◽  
Author(s):  
Simon M. Manning ◽  
Griffin Boll ◽  
Erin Fitzgerald ◽  
Debra B. Selip ◽  
Joseph J. Volpe ◽  
...  
2005 ◽  
Vol 57 (1) ◽  
pp. 1-10
Author(s):  
Lidija Radenovic ◽  
Vesna Selakovic

The involvement of NMDA and AMPA/kainate receptors in the induction of superoxide production in the rat brain was examined after intrahippocampal injection of kainate, a non-NMDA receptor agonist; kainate plus CNQX, a selective AMPA/kainate receptor antagonist; or kainate plus APV, a selective NMDA receptor antagonist. The measurements took place at different times in the ipsi- and contralateral hippocampus, forebrain cortex, striatum, and cerebellum homogenates. The used glutamate antagonists both ensured sufficient neuroprotection in the sense of lowering superoxide production and raising MnSOD levels, but in the mechanisms and time dynamics of their effects were different. Our findings suggest that NMDA and AMPA/kainate receptors are differentially involved in superoxide production. <br><br><font color="red"><b> This article has been retracted. Link to the retraction <u><a href="http://dx.doi.org/10.2298/ABS150318026E">10.2298/ABS150318026E</a><u></b></font>


1994 ◽  
Vol 664 (1-2) ◽  
pp. 41-48 ◽  
Author(s):  
A. Cudennec ◽  
D. Duverger ◽  
J. Benavides ◽  
B. Scatton ◽  
J.P. Nowicki

1993 ◽  
Vol 247 (3) ◽  
pp. 319-324 ◽  
Author(s):  
Helen J. Sherriffs ◽  
Kiyoharu Shirakawa ◽  
John S. Kelly ◽  
Henry J. Olverman ◽  
Atsushi Kuno ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document